Literature DB >> 21681985

Five years of siRNA delivery: spotlight on gold nanoparticles.

Abigail K R Lytton-Jean1, Robert Langer, Daniel G Anderson.   

Abstract

Gold nanoparticles have become widely used in scientific research due to their unique physical and chemical properties. In the last several years their use as siRNA delivery agents has been investigated. Here, progress made using gold nanoparticles for siRNA delivery is described and the different strategies employed are compared.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Mesh:

Substances:

Year:  2011        PMID: 21681985     DOI: 10.1002/smll.201100761

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  18 in total

1.  Biocompatible infinite-coordination-polymer nanoparticle-nucleic-acid conjugates for antisense gene regulation.

Authors:  Colin M Calabrese; Chad A Mirkin; Timothy J Merkel; William E Briley; Pratik S Randeria; Suguna P Narayan; Jessica L Rouge; David A Walker; Alexander W Scott
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-13       Impact factor: 15.336

Review 2.  Treating metastatic cancer with nanotechnology.

Authors:  Avi Schroeder; Daniel A Heller; Monte M Winslow; James E Dahlman; George W Pratt; Robert Langer; Tyler Jacks; Daniel G Anderson
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

Review 3.  Surface functionalization of nanoparticles for nanomedicine.

Authors:  Rubul Mout; Daniel F Moyano; Subinoy Rana; Vincent M Rotello
Journal:  Chem Soc Rev       Date:  2012-02-06       Impact factor: 54.564

Review 4.  Gold nanoparticles for nucleic acid delivery.

Authors:  Ya Ding; Ziwen Jiang; Krishnendu Saha; Chang Soo Kim; Sung Tae Kim; Ryan F Landis; Vincent M Rotello
Journal:  Mol Ther       Date:  2014-03-06       Impact factor: 11.454

5.  Gold Nanoparticle Size and Shape Effects on Cellular Uptake and Intracellular Distribution of siRNA Nanoconstructs.

Authors:  Jun Yue; Timothy Joel Feliciano; Wenlong Li; Andrew Lee; Teri W Odom
Journal:  Bioconjug Chem       Date:  2017-06-12       Impact factor: 4.774

6.  Theranostic agents for intracellular gene delivery with spatiotemporal imaging.

Authors:  Jennifer M Knipe; Jonathan T Peters; Nicholas A Peppas
Journal:  Nano Today       Date:  2013-02-01       Impact factor: 20.722

7.  Lipid-modified aminoglycoside derivatives for in vivo siRNA delivery.

Authors:  Yunlong Zhang; Jeisa M Pelet; Daniel A Heller; Yizhou Dong; Delai Chen; Zhen Gu; Brian J Joseph; Jasmine Wallas; Daniel G Anderson
Journal:  Adv Mater       Date:  2013-06-27       Impact factor: 30.849

8.  Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid Tumors.

Authors:  Yi Wen; Wilson S Meng
Journal:  J Pharm Innov       Date:  2014-06-01       Impact factor: 2.750

Review 9.  Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.

Authors:  Evelina Miele; Gian Paolo Spinelli; Ermanno Miele; Enzo Di Fabrizio; Elisabetta Ferretti; Silverio Tomao; Alberto Gulino
Journal:  Int J Nanomedicine       Date:  2012-07-20

Review 10.  Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics.

Authors:  Jianliang Shen; Wei Zhang; Ruogu Qi; Zong-Wan Mao; Haifa Shen
Journal:  Chem Soc Rev       Date:  2018-02-08       Impact factor: 60.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.